Mingyue Optical Lens Co.,Ltd. Share Price
Equities
301101
CNE1000054R1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.98 CNY | +8.45% |
|
+10.36% | +13.40% |
| Capitalization | 9.43B 1.35B 1.16B 1.08B 1.01B 1.88B 122B 2.02B 12.42B 4.89B 58.4B 5.07B 4.97B 214B | P/E ratio 2025 * |
47x | P/E ratio 2026 * | 40.4x |
|---|---|---|---|---|---|
| Enterprise value | 9.43B 1.35B 1.16B 1.08B 1.01B 1.88B 122B 2.02B 12.42B 4.89B 58.4B 5.07B 4.97B 214B | EV / Sales 2025 * |
11.1x | EV / Sales 2026 * | 9.88x |
| Free-Float |
25.98% | Yield 2025 * |
1.23% | Yield 2026 * | 1.53% |
| 1 day | +8.45% | ||
| 1 week | +10.36% | ||
| Current month | +13.40% | ||
| 1 month | +17.19% | ||
| 3 months | +14.64% | ||
| 6 months | +1.14% | ||
| Current year | +13.40% |
| 1 week | 42.25 |  | 49.9 |
| 1 month | 37.97 | | 49.9 |
| Current year | 40.9 | | 49.9 |
| 1 year | 37.55 | | 65.13 |
| 3 years | 19.84 | | 65.13 |
| 5 years | 18.81 | | 65.13 |
| 10 years | 18.81 | | 65.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gong Xing Xie
CEO | Chief Executive Officer | 53 | 14/11/2019 |
Jing Ni Wei
DFI | Director of Finance/CFO | 43 | 30/06/2022 |
Hai Feng Zhu
CTO | Chief Tech/Sci/R&D Officer | 43 | 31/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Gong Wan Xie
CHM | Chairman | 59 | 14/11/2019 |
Gong Xing Xie
BRD | Director/Board Member | 53 | 14/11/2019 |
Zhi Yun Peng
BRD | Director/Board Member | 57 | 14/11/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.45% | +10.36% | +20.25% | +8.07% | 1.35B | |
| +1.07% | +3.56% | +19.31% | +62.53% | 150B | |
| +0.19% | -1.18% | -15.88% | -7.88% | 39.19B | |
| -0.01% | -2.63% | -8.33% | -6.74% | 16.01B | |
| +2.41% | +0.99% | - | - | 8.8B | |
| -3.45% | +1.30% | +126.76% | +1,082.90% | 3.48B | |
| +1.59% | +5.92% | -2.00% | -56.26% | 2.14B | |
| +0.50% | +0.50% | +17.52% | -38.20% | 750M | |
| +1.59% | +1.59% | -19.35% | -35.10% | 710M | |
| +0.34% | +2.75% | -27.07% | -48.55% | 401M | |
| Average | +1.27% | +1.37% | +12.36% | +106.75% | 22.3B | |
| Weighted average by Cap. | +0.87% | +1.42% | +12.12% | +58.65% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 848M 122M 104M 97.14M 90.39M 169M 10.98B 182M 1.12B 439M 5.25B 456M 447M 19.24B | 954M 137M 117M 109M 102M 190M 12.36B 205M 1.26B 495M 5.91B 513M 503M 21.66B |
| Net income | 201M 28.85M 24.76M 23.05M 21.45M 40.03M 2.6B 43.15M 265M 104M 1.25B 108M 106M 4.57B | 234M 33.57M 28.8M 26.82M 24.96M 46.57M 3.03B 50.21M 308M 121M 1.45B 126M 123M 5.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 46.98 ¥ | +8.45% | 17,460,330 |
| 13/01/26 | 43.32 ¥ | -3.99% | 5,596,128 |
| 12/01/26 | 45.12 ¥ | +3.58% | 7,449,299 |
| 09/01/26 | 43.56 ¥ | +2.54% | 6,497,090 |
| 08/01/26 | 42.48 ¥ | -0.21% | 3,935,986 |
End-of-day quote Shenzhen S.E., January 13, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 301101 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition